Home » Authors » Kim Coghill

Articles by Kim Coghill

With MyVax In Phase III, Genitope Raising $51.8M In Public Offering

May 28, 2004

Syrrx Receives Milestone From Biogen Idec In Target Agreement

May 28, 2004

Crawford Asks For Review Of FDA Consulting Requests

May 24, 2004

Crawford Asks For Review Of FDA Consulting Requests

May 24, 2004

Pharmion Gets 'Full Approval' For Vidaza In MDS Subtypes

May 21, 2004

Pharmion Corp.'s value soared 47.8 percent Thursday after the FDA issued full approval of Vidaza, the firm's orphan drug for myelodysplastic syndromes (MDS). (BioWorld Today)

Pharmion Gets 'Full Approval' For Vidaza In MDS Subtypes

May 21, 2004

Pharmion Corp.'s value soared 47.8 percent Thursday after the FDA issued full approval of Vidaza, the firm's orphan drug for myelodysplastic syndromes (MDS). (BioWorld Today)

Senate Passes BioShield In 99-0 Vote; $5.6B Slated For Industry

May 20, 2004

Senate Passes BioShield In 99-0 Vote; $5.6B Slated For Industry

May 20, 2004

FDA: Critical Path Initiative' Sharpens Drug Development

May 19, 2004

FDA: Critical Path Initiative' Sharpens Drug Development

May 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 25, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...